SCHEMBL15030197

SCHEMBL15030197

CCn1c(=O)c(-c2ccc(-c3ccsc3)cc2C)cc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 3/20 0.67
PKN1 Q16512 3/20 0.67
PAK4 O96013 2/20 0.67
PAK3 O75914 2/20 0.65
PAK2 Q13177 2/20 0.65
WEE1 P30291 1/20 0.63
CDK4 P11802 6/20 0.57
CCND1 P24385 6/20 0.57
CCND2 P30279 6/20 0.57
CCND3 P30281 6/20 0.57
FGFR1 P11362 2/20 0.50
FGFR2 P21802 2/20 0.50
FGFR4 P22455 2/20 0.50
FGFR3 P22607 2/20 0.50
SRC P12931 1/20 0.50
TNK2 Q07912 2/20 0.47
CCNB2 O95067 1/20 0.47
CCNE2 O96020 1/20 0.47
CDK1 P06493 1/20 0.47
CCNB1 P14635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13554022 0.92 PAK1 (0.78) PAK1PKN1PAK4PAK3PAK2
SCHEMBL13554053 0.91 WEE1 (0.68) PAK1PKN1PAK4PAK3PAK2
SCHEMBL15030203 0.88 PAK1 (0.67) PAK1PKN1PAK4PAK3PAK2
SCHEMBL15030195 0.87 PAK1 (0.71) PAK1PKN1PAK4PAK3PAK2
SCHEMBL15030196 0.87 PAK1 (0.66) PAK1PKN1PAK4PAK3PAK2
SCHEMBL14824679 0.86 PAK1 (0.62) PAK1PKN1PAK4PAK3PAK2
SCHEMBL15035991 0.84 PAK1 (0.69) PAK1PKN1PAK4PAK3PAK2
SCHEMBL13553528 0.84 PAK1 (0.69) PAK1PKN1PAK4PAK3PAK2
SCHEMBL14824677 0.83 PAK1 (0.78) PAK1PKN1PAK4PAK3PAK2
SCHEMBL6808498 0.83 CDK4 (0.74) PAK1PKN1PAK4PAK3PAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013086451-A2 PAK INHIBITORS FOR THE TREATMENT OF CANCER AFRAXIS, INC. (US) 2013-06-13 WO disclosed